ReportWire

Tag: reproductive technology

  • Scientists Made Human Eggs from Skin Cells and Used Them to Form Embryos

    [ad_1]

    “The biggest challenge is how to make this egg extrude half of its chromosomes—and the correct half,” Amato says. “We’re not quite there yet.” The team dubbed their technique “mitomeiosis” and is trying to better understand how chromosomes like to pair and how they segregate in order to find a way to experimentally induce those conditions.

    The ability to make eggs and sperm in the lab—called in vitro gametogenesis, or IVG—has been a growing area of research in recent years.

    In 2016, a group of Japanese researchers led by stem cell researcher Katsuhiko Hayashi reported that they produced healthy mouse pups after making mouse eggs entirely in a lab dish. Later, they generated mouse eggs using cells from males and as a result, created pups with two dads. Those advancements were achieved by reprogramming skin cells from adult mice into stem cells, then further coaxing them to develop into eggs and sperm.

    Mitinori Saitou at Kyoto University first documented in 2018 how his team turned human blood cells into stem cells, which they then transformed into human eggs, but they were too immature to be fertilized to make embryos.

    US startups Conception Biosciences, Ivy Natal, Gameto, and Ovelle Bio are all working on making eggs or sperm in a lab.

    But the prospect raises significant ethical questions about how the technology should be used. In a 2017 editorial, bioethicists warned that IVG “may raise the specter of ‘embryo farming’ on a scale currently unimagined.” Conceivably, it could allow anyone at any age to have a child. And combined with advances in embryo screening, the fertility clinics of the future could use IVG to make mass numbers of embryos and then choose the ones with the most desirable qualities. Gene editing could also be used with IVG to snip out disease-causing DNA or create new traits.

    Amato says it will likely take another decade of research before IVG could be deemed safe or effective enough to be tested in people. Even then, it’s unclear if the technique would be permitted in the US, since a Congressional rider forbids the Food and Drug Administration from considering clinical trials that involve genetically manipulating an embryo for the intention of creating a baby.

    “Their method is very sophisticated and well-organized,” Hayashi, now a professor at the University of Osaka, says of the Oregon group’s approach. However, because of the high rate of chromosomal errors, “it is too inefficient and high risk to apply immediately to clinical application.”

    Also, because their process requires donor eggs, it could limit its use as an infertility treatment. As more people turn to IVF to conceive, the demand for donor eggs is increasing, and using them can involve wait times.

    Amander Clark, a reproductive scientist and stem cell biologist at UCLA who was not involved in the work, agrees that in its current form, mitomeiosis should not be offered for fertility care until more research is done. But in the meantime, the research has other uses.

    “The technology of mitomeiosis is an important technical innovation and could be highly valuable to our understanding of the biology of meiosis in human eggs. Meiotic errors increase as women age. Therefore, understanding causes of meiotic errors is a critical area of research,” Clark says.

    [ad_2]

    Emily Mullin

    Source link

  • This Woman Will Decide Which Babies Are Born

    This Woman Will Decide Which Babies Are Born

    [ad_1]

    Walk me through your own decision to do this—to use Orchid’s technology on yourself.

    I mean, I started the company because I wanted to test my own embryos.

    Because of your mom, or because of who you are as a person?

    Both. Reproduction is one of the most fundamental things in life. It’s like you die, taxes, and, you know, people have kids.

    You always knew you wanted to have kids.

    Oh, yeah. Yeah.

    How old were you when you were like, “I should be able to sequence my embryos”?

    I don’t think it was sequence my embryos specifically. I’ve always had an interest in genetics. I’ve always had an interest in fertility and reproductive tech.

    Even as, like, a teenager?

    I remember one of my applications for the Thiel Fellowship definitely had a version of Orchid on there.

    That was, what, over a decade ago, and a lot of prospective parents still rely on the same genetic testing we used back then.

    I would consider it negligent to use the old technology. Because you’re by definition missing hundreds of things that could have been detected. Parents who are not told that this new technology exists are being done a huge disservice and will probably be suing if their child ends up with a condition.

    You think that’s a legitimate lawsuit?

    Of course. If your doctor doesn’t tell you that there’s a way for you to screen for your child to not have a condition that would be either life-threatening or life-altering for them—I mean, it’s already happened. [Parents have been suing physicians for failing to perform genetic tests since the late 1980s.]

    How much does an Orchid screening cost?

    It’s $2,500 per embryo.

    And presumably you’d be screening several embryos. What about for families that can’t afford that?

    We have a philanthropic program, so people can apply to that, and we’re excited to accept as many cases as we can.

    Your clientele, at the moment, must tend toward well-off optimizers—people who really fuss about numbers.

    I guess you’re right. I mean, I don’t know.

    Do you ever worry about that? Giving people, like, more things to worry about?

    No, no, no. I think it’s the opposite. For the vast majority of our patients, it reduces worry.

    There must be exceptions.

    There are some people who, I agree, are kind of anxious. And I just don’t think they should do any genetic testing.

    Oh yeah?

    I mean, everyone’s different. It’s just that I want to expand the menu of choice. You get to choose your partner. You get to choose when and if you have kids. This is, like, this is your kid. Why would you censor information about that?

    But this still makes a lot of people extremely uncomfortable. There’s a fear, so often, around anything that touches reproduction. Are we, I don’t know, afraid of playing God or something?

    Every other time we examine something, we develop—we develop insulin, right? We’re like, “That’s great!” It’s not like you’re playing God there. But you actually are, right? You’re creating something that didn’t exist before.

    [ad_2]

    Jason Kehe

    Source link

  • Infertility affects a ‘staggering’ 1 in 6 people worldwide, WHO says | CNN

    Infertility affects a ‘staggering’ 1 in 6 people worldwide, WHO says | CNN

    [ad_1]



    CNN
     — 

    An estimated 1 in 6 people globally are affected by infertility, according to a new report from the World Health Organization, which emphasizes that the condition is common.

    Rates of infertility – defined as not being able to conceive after a year of having unprotected sex – are similar across all countries and regions, Monday’s WHO report says.

    “In our analysis, the global prevalence of lifetime infertility was 17.5%, translating into 1 out of every 6 people experiencing it in their lifetime,” Dr. Gitau Mburu, a scientist of fertility research at WHO, said Monday.

    “Lifetime prevalence of infertility does not differ by income classification of countries,” he said. “Lifetime prevalence was 17.8% in high-income countries and 16.5% in low- and middle-income countries, which, again, was not a substantial or significant difference.”

    Yet there are differences in how much people are spending on fertility treatments and how accessible such treatments are, according to the report.

    “People in the poorest countries were found to spend a significantly larger proportion of their income on a single cycle of IVF or on fertility care compared with wealthier countries,” Mburu said, “exemplifying that this is an area with high-level risk of inequality in access to health care.”

    Global public health groups typically call attention to overpopulation as a major public health concern, so the spotlight that the WHO report turns on infertility not only is surprising but is welcome, said Dr. David Keefe, reproductive endocrinologist and infertility specialist at the NYU Langone Fertility Center in New York.

    “That report did not surprise me in terms of the content, because it’s been known for some time that infertility is much more prevalent than anyone wants to think about: Having a child and having a family is kind of a universal dream or aspiration for people from every country, from every region. What surprised me was the World Health Organization coming out in support of it,” said Keefe, who was not involved with the WHO research.

    “It was a welcome acknowledgment of the other foot dropping on the population front,” he said. “The acknowledgment that this is a worldwide problem and that additional attention must be devoted to it in terms of policy and strategy is welcome.”

    The WHO report – described as the “first of its kind in a decade” – includes an analysis of infertility data from 1990 through 2021. The data came from 133 previously published studies on infertility prevalence.

    “The purpose of this analysis was to generate updated data on the global and regional estimates of infertility prevalence by analyzing all available data from different countries, making sure that we take into account different study approaches,” Mburu said.

    Based on that data, the researchers estimate that lifetime prevalence of infertility – representing the proportion of people who have ever experienced infertility in their reproductive life – was 17.5% in 2022.

    The period prevalence of infertility, meaning the proportion of people with infertility at any given point currently or in the past, was found to be 12.6% in 2022.

    Although the data showed some variation in infertility prevalence across regions – with the highest lifetime prevalence at 23.2% in the Western Pacific, compared with the lowest at 10.7% in the Eastern Mediterranean – those regional differences were not either substantial or conclusive based on the data, according to WHO’s report.

    The researchers also did not determine whether global infertility rates have been increasing or decreasing over time.

    “The data which we analyzed for this report was from 1990 to 2021, and during that period, we did not see evidence of increasing rates of infertility. However, the way the data was arranged, it was not really organized to answer that question,” Dr. James Kiarie, head of contraception and fertility care at WHO, said Monday. “We cannot, based on the data we have, say that infertility is increasing or constant – so we must say that probably the jury is still out on that question.”

    Over time, various factors can affect a person’s fertility, and age is one of the most important, said Dr. Emre Seli, chief scientific officer for the maternal and infant health nonprofit March of Dimes. Seli, who is also a professor at Yale School of Medicine and medical director of Yale Fertility Center, was not involved in the new report.

    “Fertility decreases as the age of the female partner increases,” he said.

    “Fertility is really an emotionally taxing issue for those who are affected by it. It is a major source of stress to want to have a child and not be able to,” Seli said. “Most of my patients are women, and they do become affected by this at many levels, and they do suffer from lack of adequate research as well as lack of adequate insurance coverage to undergo the treatments that they need.”

    Infertility, affecting the male or female reproductive system, can be treated with medicine, surgery or assisted reproductive technologies such as in vitro fertilization or IVF, during which an egg and sperm are joined in a lab dish and put into a womb once the fertilized egg becomes an embryo.

    “Infertility is a major and a widespread health issue affecting a staggering 1 in 6 people globally over the duration of their reproductive lives,” Dr. Pascale Allotey, director of the Sexual and Reproductive Health and Research Department at WHO, said Monday.

    Despite that, solutions for the prevention, diagnosis and treatment of infertility remain “underfunded” and “inaccessible” to many patients due to high costs, Allotey said.

    “Infertility is an important public health concern because it can have wide-reaching negative impacts on the lives of the people affected,” she said. “WHO is calling for universal access to affordable high-quality fertility care, improved data to enable infertility to be meaningfully addressed in health policy and programs, and greater efforts to ensure this issue is no longer sidelined in health research and policy.”

    Mburu added that infertility can also have effects on mental health, raising risks of anxiety, depression and intimate partner violence.

    “Our message is that infertility needs to be included as a priority in responding to the needs of populations in different countries,” Mburu said. “This is because people have a right to expect to obtain the highest possible standard of mental, social and physical health as defined by WHO.”

    The new data from WHO reinforces that more people need fertility coverage and access to high-quality care than was previously thought, said Dr. Asima Ahmad, an endocrinologist and fertility expert who serves as chief medical officer and co-founder of Carrot Fertility, a company that helps employers set up fertility benefits. She added that inequities emerge in who has such access to care, such as Black women who tend to experience inequities in access.

    “These inequities, I’m not surprised that they exist on a global level, because we already see the inequities in the United States domestically, with how infertility impacts different populations and how some populations have limited access. And even with the access that they finally get, they, for example, will have a lower rate of success or even a higher rate of miscarriage,” said Ahmad, who was not involved in the new WHO report.

    “A lot of people don’t have access to clinically vetted evidence-based information around what causes infertility, how to recognize it, and then when you do find out that you have it, how to treat it,” she said. “The other, which is one of the biggest barriers that we see, is financial access to fertility. In the United States, a lot of that access comes through the employer providing, for example, fertility benefits, but on a global level, that’s not necessarily the case, and finances tends to be the biggest barrier.”

    [ad_2]

    Source link

  • China to offer free fertility treatment in bid to boost record low birth rate | CNN

    China to offer free fertility treatment in bid to boost record low birth rate | CNN

    [ad_1]


    Hong Kong
    CNN
     — 

    China is planning to offer free fertility treatment to citizens under its national insurance scheme in a bid to reverse its plummeting birth rate.

    The National Healthcare Security Administration said on Friday it would extend its coverage to help shoulder the costs for families trying to conceive.

    It said the new coverage would include assisted reproductive technology (ART) techniques and also cover labor analgesia to ease pain in childbirth. The most commonly performed ART procedure is in vitro fertilization (IVF).

    The administration described China’s falling population as one of the biggest obstacles to national development and stressed it had already added ovulation-inducing drugs to its coverage, to help “reduce the burden of infertility.”

    The expanded coverage is part of a wider attempt by Chinese authorities to persuade more people to get married and have more children.

    The country’s birthrate has been falling for years and last year the country recorded its first population decline in more than 60 years.

    The country’s population fell to 1.411 billion in 2022, a drop of 850,000 people from the previous year, according to China’s National Bureau of Statistics (NBS).

    At the same time, the birthrate fell to a record low of 6.77 births per 1,000 people. Some 9.56 million babies were born in 2022, compared with 10.62 million in 2021.

    An increasing number of women in China are delaying marriages and choosing not to have children, often citing financial constraints, and the need to prioritize careers, according to Chen Wei, a professor at China’s Renmin University. Options covering costly procedures such as IVF may help to alleviate some of these pressures, said Chen. The average cost associated with IVF in cities such as Shanghai is between $4,500 to $5,000.

    China has 539 ART-approved medical institutions and 27 sperm banks as of June 2021, and each year these facilities facilitate more than one million IVF cycles, according to experts from the country’s National Clinical Research Center for Obstetrics and Gynecology.

    Policymakers are increasingly concerned about the impact China’s growing demographic crisis could have on economic growth.

    China introduced a highly controversial “one child” policy decades ago in an attempt to address fears of overpopulation and alleviate poverty, but decided to scrap it in 2015 amid concerns a rapidly aging population and shrinking workforce could threaten economic and social stability.

    Initially, it allowed couples to have up to two children, but later further loosened the policy to allow up to three.

    Chinese authorities are also moving to drop restrictions on registering the births of children born to unmarried parents in a country where unwed mothers still face stigma.

    In February, the provincial health commission of Sichuan – which is home to over 83 million people – said it would allow single parents to register the birth of their children, a move that granted them access to benefits previously reserved for married couples. These benefits included maternity insurance that covers prenatal healthcare, childbirth-related medical expenses and paid maternity leave.

    [ad_2]

    Source link